Revenue (Tables)

3 Months Ended

Apr. 03, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three-month periods ended April 3, 2020 and March 29, 2019 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.

	Life Sciences		Diagnostics		Environmental & Applied Solutions		Total
Three-month period ended April 3, 2020:
Geographical region:
North America	$	620.7	$	754.7	$	496.9	$	1,872.3
Western Europe	471.6		309.8		256.0		1,037.4
Other developed markets	152.8		98.7		30.3		281.8
High-growth markets (a)	405.3		463.8		282.5		1,151.6
Total	$	1,650.4	$	1,627.0	$	1,065.7	$	4,343.1
Revenue type:
Recurring	$	1,159.4	$	1,427.9	$	619.6	$	3,206.9
Nonrecurring	491.0		199.1		446.1		1,136.2
Total	$	1,650.4	$	1,627.0	$	1,065.7	$	4,343.1
Three-month period ended March 29, 2019:
Geographical region:
North America	$	587.3	$	632.4	$	449.2	$	1,668.9
Western Europe	460.3		288.9		259.7		1,008.9
Other developed markets	149.3		92.0		28.9		270.2
High-growth markets (a)	430.0		523.5		318.7		1,272.2
Total	$	1,626.9	$	1,536.8	$	1,056.5	$	4,220.2
Revenue type:
Recurring	$	1,068.2	$	1,324.1	$	582.2	$	2,974.5
Nonrecurring	558.7		212.7		474.3		1,245.7
Total	$	1,626.9	$	1,536.8	$	1,056.5	$	4,220.2

^(a) The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets that are not high-growth markets.